Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

VCP binding influences intracellular distribution of the slow Wallerian degeneration protein, Wld(S).

Wilbrey AL, Haley JE, Wishart TM, Conforti L, Morreale G, Beirowski B, Babetto E, Adalbert R, Gillingwater TH, Smith T, Wyllie DJ, Ribchester RR, Coleman MP.

Mol Cell Neurosci. 2008 Jul;38(3):325-40. doi: 10.1016/j.mcn.2008.03.004. Epub 2008 Mar 25.

PMID:
18468455
2.

WldS can delay Wallerian degeneration in mice when interaction with valosin-containing protein is weakened.

Beirowski B, Morreale G, Conforti L, Mazzola F, Di Stefano M, Wilbrey A, Babetto E, Janeckova L, Magni G, Coleman MP.

Neuroscience. 2010 Mar 10;166(1):201-11. doi: 10.1016/j.neuroscience.2009.12.024. Epub 2009 Dec 16.

PMID:
20018231
3.

The slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus.

Laser H, Conforti L, Morreale G, Mack TG, Heyer M, Haley JE, Wishart TM, Beirowski B, Walker SA, Haase G, Celik A, Adalbert R, Wagner D, Grumme D, Ribchester RR, Plomann M, Coleman MP.

Mol Biol Cell. 2006 Mar;17(3):1075-84. Epub 2005 Dec 21.

4.

Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration.

Yahata N, Yuasa S, Araki T.

J Neurosci. 2009 May 13;29(19):6276-84. doi: 10.1523/JNEUROSCI.4304-08.2009.

5.

Degeneration of neuronal cell bodies following axonal injury in Wld(S) mice.

Wang AL, Yuan M, Neufeld AH.

J Neurosci Res. 2006 Dec;84(8):1799-807.

PMID:
17022038
6.

The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.

Mi W, Beirowski B, Gillingwater TH, Adalbert R, Wagner D, Grumme D, Osaka H, Conforti L, Arnhold S, Addicks K, Wada K, Ribchester RR, Coleman MP.

Brain. 2005 Feb;128(Pt 2):405-16. Epub 2005 Jan 11.

PMID:
15644421
7.

Wld S requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration.

Avery MA, Sheehan AE, Kerr KS, Wang J, Freeman MR.

J Cell Biol. 2009 Feb 23;184(4):501-13. doi: 10.1083/jcb.200808042.

8.

Identification of a critical site in Wld(s): essential for Nmnat enzyme activity and axon-protective function.

Jia H, Yan T, Feng Y, Zeng C, Shi X, Zhai Q.

Neurosci Lett. 2007 Feb 8;413(1):46-51. Epub 2006 Dec 15.

PMID:
17207927
9.

The slow Wallerian degeneration gene in vivo protects motor axons but not their cell bodies after avulsion and neonatal axotomy.

Adalbert R, Nógrádi A, Szabó A, Coleman MP.

Eur J Neurosci. 2006 Oct;24(8):2163-8.

PMID:
17074042
10.

Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice.

Conforti L, Wilbrey A, Morreale G, Janeckova L, Beirowski B, Adalbert R, Mazzola F, Di Stefano M, Hartley R, Babetto E, Smith T, Gilley J, Billington RA, Genazzani AA, Ribchester RR, Magni G, Coleman M.

J Cell Biol. 2009 Feb 23;184(4):491-500. doi: 10.1083/jcb.200807175.

11.

Genotyping methods to detect a unique neuroprotective factor (Wld(s)) for axons.

Mi W, Conforti L, Coleman MP.

J Neurosci Methods. 2002 Jan 30;113(2):215-8.

PMID:
11772443
12.

Prion disease development in slow Wallerian degeneration (Wld(S)) mice.

Gültner S, Laue M, Riemer C, Heise I, Baier M.

Neurosci Lett. 2009 Jun 5;456(2):93-8. doi: 10.1016/j.neulet.2009.03.089. Epub 2009 Apr 1.

PMID:
19429141
13.

Axotomy-dependent and -independent synapse elimination in organ cultures of Wld(s) mutant mouse skeletal muscle.

Parson SH, Ribchester RR, Davie N, Gandhi NP, Malik RQ, Gillingwater TH, Thomson D.

J Neurosci Res. 2004 Apr 1;76(1):64-75.

PMID:
15048930
14.

NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration.

Conforti L, Fang G, Beirowski B, Wang MS, Sorci L, Asress S, Adalbert R, Silva A, Bridge K, Huang XP, Magni G, Glass JD, Coleman MP.

Cell Death Differ. 2007 Jan;14(1):116-27. Epub 2006 Apr 28.

15.

Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo.

Babetto E, Beirowski B, Janeckova L, Brown R, Gilley J, Thomson D, Ribchester RR, Coleman MP.

J Neurosci. 2010 Oct 6;30(40):13291-304. doi: 10.1523/JNEUROSCI.1189-10.2010.

16.

Expression of the neuroprotective slow Wallerian degeneration (WldS) gene in non-neuronal tissues.

Wishart TM, Brownstein DG, Thomson D, Tabakova AM, Boothe KM, Tsao JW, Gillingwater TH.

BMC Neurosci. 2009 Dec 16;10:148. doi: 10.1186/1471-2202-10-148.

17.

Wallerian degeneration slow mouse neurons are protected against cell death caused by mechanisms involving mitochondrial electron transport dysfunction.

Tokunaga S, Araki T.

J Neurosci Res. 2012 Mar;90(3):664-71. doi: 10.1002/jnr.22792. Epub 2011 Dec 20.

PMID:
22183770
18.

A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses.

Adalbert R, Gillingwater TH, Haley JE, Bridge K, Beirowski B, Berek L, Wagner D, Grumme D, Thomson D, Celik A, Addicks K, Ribchester RR, Coleman MP.

Eur J Neurosci. 2005 Jan;21(1):271-7.

PMID:
15654865
19.

Stable inheritance of an 85-kb triplication in C57BL/WldS mice.

Mi W, Glass JD, Coleman MP.

Mutat Res. 2003 May 15;526(1-2):33-7.

PMID:
12714180
20.

Supplemental Content

Support Center